<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Ducommun S</dc:creator>
  <dc:creator>Deak M</dc:creator>
  <dc:creator>Zeigerer A</dc:creator>
  <dc:creator>Göransson O</dc:creator>
  <dc:creator>Seitz S</dc:creator>
  <dc:creator>Collodet C</dc:creator>
  <dc:creator>Madsen AB</dc:creator>
  <dc:creator>Jensen TE</dc:creator>
  <dc:creator>Viollet B</dc:creator>
  <dc:creator>Foretz M</dc:creator>
  <dc:creator>Gut P</dc:creator>
  <dc:creator>Sumpton D</dc:creator>
  <dc:creator>Sakamoto K</dc:creator>
  <dc:date>2019</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">AMP-activated protein kinase (AMPK) is a key regulator of cellular energy homeostasis, acting as a sensor of energy and nutrient status. As such, AMPK is considered a promising drug target for treatment of medical conditions particularly associated with metabolic dysfunctions. To better understand the downstream effectors and physiological consequences of AMPK activation, we have employed a chemical genetic screen in mouse primary hepatocytes in an attempt to identify novel AMPK targets. Treatment of hepatocytes with a potent and specific AMPK activator 991 resulted in identification of 65 proteins phosphorylated upon AMPK activation, which are involved in a variety of cellular processes such as lipid/glycogen metabolism, vesicle trafficking, and cytoskeleton organisation. Further characterisation and validation using mass spectrometry followed by immunoblotting analysis with phosphorylation site-specific antibodies identified AMPK-dependent phosphorylation of Gapex-5 (also known as GTPase-activating protein and VPS9 domain-containing protein 1 (GAPVD1)) on Ser902 in hepatocytes and starch-binding domain 1 (STBD1) on Ser175 in multiple cells/tissues. As new promising roles of AMPK as a key metabolic regulator continue to emerge, the substrates we identified could provide new mechanistic and therapeutic insights into AMPK-activating drugs in the liver.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/209830</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cellsig.2019.02.001</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/30772465</dc:relation>
  <dc:source>Cellular signalling. - 2019</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">GTPase activating protein and VPS9 domains 1</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Shokat</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Starch-binding domain 1</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">AMP-Activated Protein Kinases</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Guanine Nucleotide Exchange Factors</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Hepatocytes</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Homeostasis</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Lipid Metabolism</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Liver</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Mass Spectrometry</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Membrane Proteins</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Mice, Knockout</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Muscle Proteins</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Phosphorylation</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Substrate Specificity</dc:subject>
  <dc:title xmlns:ns17="xml" ns17:lang="en">Chemical genetic screen identifies Gapex-5/GAPVD1 and STBD1 as novel AMPK substrates.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
